DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 51 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $734,000 | -49.7% | 36,401 | -6.8% | 0.00% | 0.0% |
Q2 2021 | $1,458,000 | +52.0% | 39,069 | +4.1% | 0.00% | 0.0% |
Q1 2021 | $959,000 | +9.0% | 37,517 | -6.1% | 0.00% | 0.0% |
Q4 2020 | $880,000 | +28.1% | 39,933 | +4.6% | 0.00% | 0.0% |
Q3 2020 | $687,000 | -28.5% | 38,179 | -1.7% | 0.00% | 0.0% |
Q2 2020 | $961,000 | +54.3% | 38,859 | +14.5% | 0.00% | 0.0% |
Q1 2020 | $623,000 | -10.9% | 33,940 | +7.0% | 0.00% | 0.0% |
Q4 2019 | $699,000 | +39.2% | 31,716 | -4.1% | 0.00% | 0.0% |
Q3 2019 | $502,000 | -3.6% | 33,058 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $521,000 | -1.3% | 33,058 | -8.3% | 0.00% | 0.0% |
Q1 2019 | $528,000 | +57.1% | 36,046 | +14.4% | 0.00% | – |
Q4 2018 | $336,000 | -28.2% | 31,503 | +2.8% | 0.00% | – |
Q3 2018 | $468,000 | +10.9% | 30,633 | -11.0% | 0.00% | – |
Q2 2018 | $422,000 | +2382.4% | 34,437 | +1787.0% | 0.00% | – |
Q1 2018 | $17,000 | +142.9% | 1,825 | +126.4% | 0.00% | – |
Q4 2017 | $7,000 | +250.0% | 806 | +25.5% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 642 | -4.3% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 671 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | -50.0% | 671 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | +100.0% | 671 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -96.5% | 671 | -93.9% | 0.00% | – |
Q1 2016 | $57,000 | -52.9% | 11,066 | +8.4% | 0.00% | – |
Q4 2015 | $121,000 | +45.8% | 10,205 | 0.0% | 0.00% | – |
Q3 2015 | $83,000 | -39.0% | 10,205 | +4.4% | 0.00% | – |
Q2 2015 | $136,000 | +806.7% | 9,777 | +1487.2% | 0.00% | – |
Q1 2015 | $15,000 | +50.0% | 616 | 0.0% | 0.00% | – |
Q4 2014 | $10,000 | -47.4% | 616 | -59.2% | 0.00% | – |
Q3 2014 | $19,000 | – | 1,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|